This study tests a personalized DNA vaccine (GNOS-PV02) plus an immune booster (INO-9012) combined with the immunotherapy drug pembrolizumab in 36 adults with advanced hepatocellular carcinoma (HCC), a type of liver cancer. The vaccine is custom-made for each patient based on the…
Phase: PHASE1, PHASE2 • Sponsor: Geneos Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:21 UTC